Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Dec 7-9
2021
INOVOTION WILL ATTEND THE BIOFIT 2021
Exploring new options for your oncology Drug Discovery needs? Join Inovotion at this exciting event held December 7-9 and learn about our game-changing, in vivo technology and how it can revolutionize your preclinical […]
Nov 18
2021
Webinar #4: The CAM Assay: From Efficacy/Toxicity Studies to Mechanisms of Action Analysis
Webinar Description: Understanding the mechanisms of action of new drugs is a key success factor for efficient drug discovery. It’s necessary for: Anticipating problems relating to clinical safety Determining the site of […]
Nov 9-11
2021
INOVOTION WILL ATTEND THE FESTIVAL OF BIOLOGICS
Join Inovotion at this must-attend event ! Let’s talk about R&D antibodies for oncology! Join Inovotion at this must-attend event held November 9-11. Our Head of Business Development Philippe Fornies will be […]
